230 related articles for article (PubMed ID: 9626466)
21. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma.
Maehara Y; Kabashima A; Koga T; Tokunaga E; Takeuchi H; Kakeji Y; Sugimachi K
Surgery; 2000 Sep; 128(3):408-16. PubMed ID: 10965312
[TBL] [Abstract][Full Text] [Related]
22. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
23. Different angiogenic pathways in human cervical cancers.
Tokumo K; Kodama J; Seki N; Nakanishi Y; Miyagi Y; Kamimura S; Yoshinouchi M; Okuda H; Kudo T
Gynecol Oncol; 1998 Jan; 68(1):38-44. PubMed ID: 9454658
[TBL] [Abstract][Full Text] [Related]
24. Tumor angiogenesis as a major prognostic factor in stage I lung adenocarcinoma.
Kawaguchi T; Yamamoto S; Kudoh S; Goto K; Wakasa K; Sakurai M
Anticancer Res; 1997; 17(5B):3743-6. PubMed ID: 9427772
[TBL] [Abstract][Full Text] [Related]
25. Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer.
Stefanou D; Goussia AC; Arkoumani E; Agnantis NJ
Anticancer Res; 2003; 23(6C):4715-20. PubMed ID: 14981918
[TBL] [Abstract][Full Text] [Related]
26. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease.
Fukuda S; Shirahama T; Imazono Y; Tsushima T; Ohmori H; Kayajima T; Take S; Nishiyama K; Yonezawa S; Akiba S; Akiyama S; Ohi Y
Cancer; 1999 Mar; 85(6):1323-30. PubMed ID: 10189138
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
Crew JP; O'Brien T; Bradburn M; Fuggle S; Bicknell R; Cranston D; Harris AL
Cancer Res; 1997 Dec; 57(23):5281-5. PubMed ID: 9393750
[TBL] [Abstract][Full Text] [Related]
28. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
29. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.
Ohta Y; Oda M; Wu J; Tsunezuka Y; Hiroshi M; Nonomura A; Watanabe G
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):900-6. PubMed ID: 11689794
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma.
Ozbudak IH; Ozbilim G; Kucukosmanoglu I; Dertsiz L; Demircan A
Int J Surg Pathol; 2009 Oct; 17(5):390-5. PubMed ID: 18849317
[TBL] [Abstract][Full Text] [Related]
31. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.
Shih CH; Ozawa S; Ando N; Ueda M; Kitajima M
Clin Cancer Res; 2000 Mar; 6(3):1161-8. PubMed ID: 10741747
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer.
Yilmaz A; Ernam D; Unsal E; Demirag F; Atikcan S; Taştepe I
Arch Med Res; 2007 Oct; 38(7):764-8. PubMed ID: 17845896
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas.
Hida Y; Morita T; Fujita M; Miyasaka Y; Horita S; Fujioka Y; Nagashima K; Katoh H
Anticancer Res; 1999; 19(3B):2257-60. PubMed ID: 10472340
[TBL] [Abstract][Full Text] [Related]
35. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
36. Angiostatin expression in endometrial cancer.
Yabushita H; Noguchi M; Kinoshita S; Kishida T; Sawaguchi K; Noguchi M
Oncol Rep; 2002; 9(6):1193-6. PubMed ID: 12375018
[TBL] [Abstract][Full Text] [Related]
37. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer.
Inoshima N; Nakanishi Y; Minami T; Izumi M; Takayama K; Yoshino I; Hara N
Clin Cancer Res; 2002 Nov; 8(11):3480-6. PubMed ID: 12429638
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of angiogenesis in human pancreatic cancer.
Ikeda N; Adachi M; Taki T; Huang C; Hashida H; Takabayashi A; Sho M; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M
Br J Cancer; 1999 Mar; 79(9-10):1553-63. PubMed ID: 10188906
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]